PUBLIC CITIZEN for PUBLIC CITIZEN
What was lobbied
13 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
NAFTA, NAFTA renegotiation,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LORI WALLACH | — |
Banking BAN
S 2155-Economic Growth Regulatory Relief and Consumer Protection Act, HR 1264-Community Financial Institutions Exemption Act, HR 1426-Federal Savings Association Charter Flexibility Act of 2017, HR 2226-Portfolio Lending and Mortgage Access Act, HR 3299-Protecting Consumer Access to Credit Act of 2017, HR 2978-Voting Rights Advancement Act of 2017, HR 4296-Place requirements on operational risk capital requirements for banking organizations established by appropriate federal banking agency, HR 1116-TAILOR Act, HR 4061-Financial Stability Oversight Council Improvement Act of 2017, HR 4263-Regulatory A+ Improvement Act of 2017, HR 4545-Financial Institutions Examination Fairness and Reform Act, HR 4293-STRESS Test Improvement Act of 2017, HR 4566-Alleviating Stress Test burdens to help investors act, Anti-trust remedies, Fighting the Crapo bank deregulatory bill,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| BARTLETT NAYLOR | — |
Civil Rights/Civil Liberties CIV
#Metoo legislation as connected to employment forced arbitration clauses, SEC issues, METOO issues, reforming procedures for reporting discrimination and harassment, sexual harassment reforms, arbitration, civil justice issues,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| REMINGTON GREGG | — |
Agriculture AGR
Infrastructure discussion and impact on rural areas
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
Consumer Issues/Safety/Products CSP
Regulatory reform, S 2296-Guidance out of Darkness Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMIT NARANG | — |
Government Issues GOV
Inaugural Funds accountability, S 625-Foreign Agents Registration Modernization and Enforcement Act, Congressional earmarking, Strengthen Office of Government Ethics, S 2039, HR 4170- Disclosing Foreign Influence Act, Protect the Russia/Trump investigation, support a broad democracy package,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| CRAIG HOLMAN | — |
Health Issues HCR
Single Payer Health Care, Right to Try/False Hope, drug pricing
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| EAGAN KEMP | — |
Budget/Appropriations BUD
Keep the budget free from poison pill riders, CPC People's budget,
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
| SUSAN ELAINE HARLEY | — |
Transportation TRA
Infrastructure investments
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
Labor Issues/Antitrust/Workplace LBR
Congressional sexual harassment & whistleblower reform, S 2159/HR 4396-ME TOO Congress Act, workplace safety legislation, DOL tip pooling proposal,
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHANNA DEVINE | — |
Taxation/Internal Revenue Code TAX
Oppose Johnson Amendment riders, Support Bright Lines Project Legislation, Wall Street Speculation Tax/Financial Transaction tax, No tax breaks for outsourcing Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
| EMILY PETERSON CASSIN | — |
Financial Institutions/Investments/Securities FIN
Opposing the Crapo financial deregulation bill, Supporting Dodd-Frank executive pay regulations
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA JEAN GILBERT | — |
Pharmacy PHA
S. 771/HR 1776-Improving access to affordable Prescription Drugs act, S 2157-Drug Price transparency in Communications Act, S 2011/HR 4138-Medicare drug price negotiation act of 2017, S 1688-Empowering medicare seniors to negotiate drug prices of 2017, S 252-Medicare drug savings act of 2017, S 1369/HR 2974-Stop Price gouging act, S 124-Preserve access to affordable generics act, S 974/HR 2212-CREATES Act of 2017, S 495-Medical Innovation and Prize Fund Act, S 1131/HR 2439-FAIR drug pricing act, Over-the-counter Monograph Safety, Innovation, and Reform Act of 2018, HR 4117-Competitive DRUGS Act of 2017), HR 2051- FAST Generics Act of 2017), Prescription drug pricing, PACED Act, S 771/HR 1776 (Improving access to affordable prescription drugs act, S 1509/HR 1223 OPEN Act), S 1309-Stronger patents act, HR 5150 Protecting Medicare from excessive price increases act, S 2476-Expanding access to low cost generics act, S 637 (c-thru act), S 1348-SPIKE act,
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN KNIEVEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.